First Time Loading...

Addex Therapeutics Ltd
SIX:ADXN

Watchlist Manager
Addex Therapeutics Ltd Logo
Addex Therapeutics Ltd
SIX:ADXN
Watchlist
Price: 0.0664 CHF -2.64% Market Closed
Updated: Jun 1, 2024

Addex Therapeutics Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Addex Therapeutics Ltd
Total Liabilities & Equity Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Addex Therapeutics Ltd
SIX:ADXN
Total Liabilities & Equity
CHf6.1m
CAGR 3-Years
-33%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Total Liabilities & Equity
CHf182.8m
CAGR 3-Years
-9%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Total Liabilities & Equity
$2.4B
CAGR 3-Years
8%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Total Liabilities & Equity
CHf173.3m
CAGR 3-Years
-9%
CAGR 5-Years
-9%
CAGR 10-Years
-5%
Idorsia Ltd
SIX:IDIA
Total Liabilities & Equity
CHf500m
CAGR 3-Years
-30%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Total Liabilities & Equity
CHf71.5m
CAGR 3-Years
-9%
CAGR 5-Years
-4%
CAGR 10-Years
N/A

See Also

What is Addex Therapeutics Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
6.1m CHF

Based on the financial report for Dec 31, 2023, Addex Therapeutics Ltd's Total Liabilities & Equity amounts to 6.1m CHF.

What is Addex Therapeutics Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
-32%

Over the last year, the Total Liabilities & Equity growth was -50%. The average annual Total Liabilities & Equity growth rates for Addex Therapeutics Ltd have been -33% over the past three years , -32% over the past five years .